[1]董伟伟,吴彩兰.甲状腺功能亢进症与血栓形成相关性研究进展[J].陕西医学杂志,2021,50(2):251-253，封3.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.032]
　DONG Weiwei,WU Cailan.Research progress on the relationship between hyperthyroidism and thrombosis[J].,2021,50(2):251-253，封3.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.032]
点击复制

甲状腺功能亢进症与血栓形成相关性研究进展
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
50
期数:
2021年2期
页码:
251-253，封3
栏目:
综述
出版日期:
2021-02-05

文章信息/Info

Title:
Research progress on the relationship between hyperthyroidism and thrombosis
作者:
董伟伟; 吴彩兰
(天津市第四中心医院核医学科,天津 300140)
Author(s):
DONG Weiwei; WU Cailan
(Department of Nuclear Medicine,Tianjin Fourth Central Hospital,Tianjin 300140,China)
关键词:
甲状腺功能亢进症;  凝血;  血栓形成;  内皮损伤;  血小板;  纤维蛋白原
Keywords:
Hyperthyroidism;  Coagulation;  Thrombopoiesis;  Endothelial injury;  Platelet;  Fibrinogen
分类号:
R 581.1
DOI:
DOI:10.3969/j.issn.1000-7377.2021.02.032
文献标志码:
A
摘要:
甲状腺功能亢进症是内分泌常见疾病之一,难治愈、易反复,对全身各个系统都有直接或间接作用。甲状腺功能亢进症影响凝血系统,较高水平的甲状腺激素可使机体处于高凝状态,凝血因子Ⅷ、Ⅸ、Ⅹ,血管性血友病因子(vWF),纤溶酶原激活物抑制剂-1含量增多,增加了动静脉血栓和致死风险,即使正常参考范围内的游离甲状腺素(FT4)水平也与凝血因子Ⅷ、vWF有剂量相关性。心肌和血管内皮细胞有甲状腺激素作用的受体,并且对激素水平的变化很敏感。甲状腺功能亢进症诱发房颤中脑栓塞事件发生率增高,但也有甲状腺功能亢进症合并房颤患者中并未见栓塞事件风险增加的报道。动物水平研究中发现甲状腺功能亢进症可使内皮细胞损伤,可能是发生心脑血管疾病(特别是血管栓塞)的危险因素。许多细胞水平研究文章报道高碘环境可引起内皮细胞增殖和损伤,但也有研究报道高碘饮食老鼠内皮细胞未发生明显伤害。现就甲状腺功能亢进症与血栓形成相关性研究进展进行综述。
Abstract:
Hyperthyroidism is one of the common endocrine diseases.It is difficult to cure and easy to repeat.It has direct or indirect effects on all systems of the body.Hyperthyroidism affects the coagulation system.Higher levels of thyroid hormones can make the body in a hypercoagulable state.The increase of coagulation factors Ⅷ,Ⅸ,Ⅹ,von Willebrand factor(vWF),and plasminogen activator inhibitor-1 increases the risk of arteriovenous thrombosis and death.Even the free thyroxine(FT4)level within the normal reference range is dose-related with coagulation factor Ⅷ and vWF.Myocardium and vascular endothelial cells have receptors for thyroid hormones and are sensitive to changes in hormone levels.Hyperthyroidism induces an increased incidence of cerebral embolism in atrial fibrillation,but there are no reports of increased risk of embolism in patients with hyperthyroidism and atrial fibrillation.Animal-level studies have found that hyperthyroidism can damage endothelial cells,which may be a risk factor for cardiovascular and cerebrovascular diseases(especially vascular embolism).Many research articles at the cellular level report that high iodine environment can cause endothelial cell proliferation and damage,but there are also studies that report that the endothelial cells of rats with high iodine diet did not cause significant damage.This article reviews the research progress of the relationship between hyperthyroidism and thrombosis.

参考文献/References:

[1] 王 峰,肖 瑾.急性脑梗死患者预后不佳的相关危险因素分析[J].中国急救复苏与灾害医学杂志,2017,12(5):414-417.
[2] 戴文锋,王 冠,董 琨,等.化瘀通络汤对急性脑梗死患者神经功能与炎性反应标志物的影响[J].陕西中医,2020,41(8):1059-1061,1065.
[3] 张 玲,郭利军.氢氯吡格雷与替格瑞洛在急性ST段抬高型心肌梗死合并2型糖尿病患者经皮冠状动脉介入治疗中的效果观察[J].陕西医学杂志,2020,49(10):1339-1342.
[4] Tohidi M,Derakhshan A,Akbarpour S,et al.Thyroid dysfunction states and incident cardiovascular events:The tehran thyroid study[J].Hormone and Metabolic Research,2018,50(1):37-43.
[5] Rennie JA,Bewsher PD,Murchison LE,et al.Coagulation and fibrinolysis in thyroid disease[J].Acta Haematol,1978,59:171-177.
[6] 常曼丽,于天龙,景 淼,等.甲状腺功能亢进症与血管内皮损伤关系的临床研究[J].中华地方病学杂志,2019,38(11):918-921.
[7] Yu TL,Miao J,Gao Y,et al.Study on the relationship between hyperthyroidism and vascular endothelial cell damage[J].Scientific Reports,2020,10(1):6992.
[8] Thoyyib M,Garg S,Gupta N,et al.Study on coagulation factor Ⅷ and fibrinogen levels in patients with thyroid disorders[J].Indian Journal of Endocrinology and Metabolism,2018,22(4):479-484.
[9] Antonis AA,Manolis TA,Melita H,et al.Subclinical thyroid dysfunction and cardiovascular consequences:An alarming wake-up call?[J].Trends Cardiovasc Med,2020,30(2):57-69.
[10] Bano A,Chaker L,De Maat MPM,et al.Thyroid function and cardiovascular disease:The mediating role of coagulationfactors[J].J Clin Endocrinol Metab,2019,104(8):3203-3212.
[11] Ito S,Fujiwara SI,Murahashi R,et al.Clinical association between thyroid disease and immune thrombocytopenia[J].Ann Hematol,2020,9:238.
[12] Erem C,Civan N,Coskun H,et al.Signal peptide-CUB-EGF domain-containing protein 1(SCUBE1)levels in patients with overt and subclinical hyperthyroidism:Effects of treatment[J].Clinical Endocrinology,2016,84(6):919-924.
[13] 付立强,高吉贤,马 静,等.131I治疗诱发心血管意外高风险患者严重急性心肌梗死一例[J].中华医学杂志,2018,98(1):65-66.
[14] Wang LQ,Yang JG,Zheng JP,et al.Acute myocardial infarction in pregnancy:Spasm caused byhyperthyroidism[J].J Int Med Res,2019,47(5):2269-2273.
[15] Iiya M,Yamawake N,Nishizaki M,et al.Ventricular fibrillation induced by coronary vasospasm in a patient with early repolarization and hyperthyroidism[J].Internal Medicine,2018,57(23):3389-3392.
[16] Hieber M,von Kageneck C,Weiller C,et al.Thyroid diseases are an underestimated risk factor for cerebral venous sinus thrombosis[J].Front Neurol,2020,11:561656.
[17] Kim TY,Ihm SH,Roh JW,et al.Massive pulmonary thromboembolism combined with transient thyrotoxicosis in an 18 year old girl[J].Clin Hypertens,2020,26:17.
[18] Salloum-Asfar S,Boelen A,Reitsma PH,et al.The immediate and late effects of thyroid hormone(triiodothyronine)on murine coagulation gene transcription[J].PLoS One,2015,10(5):127469.
[19] Elbers LP,Moran C,Gerdes VE,et al.The hypercoagulable state in hyperthyroidism is mediated via the thyroid hormone β receptor pathway[J].Eur J Endocrinol,2016,174(6):755-762.
[20] Krieg VJ,Hobohm L,Liebetrau C,et al.Risk factors for chronic thromboembolic pulmonary hypertension - Importance of thyroid disease and function[J].Thromb Res,2020,185:20-26.

相似文献/References:

[1]庄 焱.血管性血友病因子抗原与VITRO评分对乙型肝炎肝硬化预后的预测价值[J].陕西医学杂志,2023,52(8):1059.[doi:DOI:10.3969/j.issn.1000-7377.2023.08.027]
[2]叶惠成,刘玉华,禤文婷.甲状腺功能亢进症患者甲状腺激素水平变化及其与冠心病发生关系研究[J].陕西医学杂志,2024,(6):764.[doi:DOI:10.3969/j.issn.1000-7377.2024.06.009]
　YE Huicheng,LIU Yuhua,XUAN Wenting.Changes of thyroid hormone levels in patients with hyperthyroidism and their relationship with occurrence of coronary heart disease[J].,2024,(2):764.[doi:DOI:10.3969/j.issn.1000-7377.2024.06.009]

更新日期/Last Update: 2021-01-28